Injectable GHK-Cu offers systemic and often faster-acting effects, delivering higher bioavailability to deeper tissues
No, they are not the same
(b) Single small case series in knee pain A peer-reviewed article (Lee et al., Alternative Therapies in Health & Medicine , ~2021) describes: 12 patients with chronic knee pain Treated with intra-articular BPC-157, often combined with TB-500 7 of 12 reported symptom improvement lasting several months This study has major limitations: No control group No blinding No standardized outcomes (no KOOS, WOMAC, or imaging) Very small sample size Mixed interventions Conclusion: This study cannot demonstrate true benefit
One practical note: some people on KLOW experience mild water retention, particularly at higher doses
Researchers have studied GHK and GHK-Cu for decades in connection with tissue repair, wound healing, collagen regulation, antioxidant activity, and inflammation
Front Pharmacol 14:1107507